Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: doug doan who wrote (1117)	1/18/1999 11:13:00 PM
From: Amigo Mike	Read Replies (2) \| Respond to of 1476

Hi Doug, 1. Yes funding comes from those three sources plus grants from institutions like NIH. 2. Current trials, Campy Phase II, H Pylori Phase I, H Influenzae Phase I. There are four others in clinical research including Chlamydia for sexually transmitted diseases and nisseria (sp) another form of childrens ear infection. 3. Antex is a developement stage company. All revenue is generated as a result of trial funding and grants. Hope this helps, Amigo Mike